Company and Stock Identity
How Owkin Connects to the Public Market
- Company structure
- Private company
- Market access
- No current public listing was verified.
- Research focus
- Separate research-platform agreements from drug-development milestones. Repeatable analysis and experimental validation answer different questions.
Owkin is privately held. Company sources are the starting point for ownership and business updates.
Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.
First-Hand Company News
Latest Developments
Owkin and Estonia will test AI research inside national health-data systems
Owkin and Estonia's applied research center Metrosert announced an evaluation of K Pro within secure national infrastructure. The first phase will use selected health-data groups and explore research areas including oncology.
Why it matters: The collaboration tests whether AI research can work within national data controls. It is an evaluation plan, so useful evidence will come from repeatable analyses and the research produced.
Careers and Qualifications
What to Know Before Applying
Work areas: Biomedical research teams work with AI and software engineers. Clinical partnerships connect the work with hospitals and drug developers.
Qualification signal: Biomedical roles need training that fits the research. Technical work benefits from evidence that analyses can be reproduced on complex health data.
Check current roles at Owkin. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.
Related Healthcare AI Roles
Training to Compare
- Applied data science and AI short programs ... MIT Professional Education
- AI for Medicine Specialization ... DeepLearning.AI, delivered on Coursera
Buyer Snapshot
- Best-fit buyer
- Pharmaceutical R&D, biotechnology leadership, translational science, business development, and investors
- Primary use case
- Identify targets, design molecules, prioritize experiments, and connect biomedical data to research decisions
- Typical deployment
- Ranges from software and data partnerships to platform collaborations and internally owned drug pipelines
Evidence questions
- Which results are prospective, reproduced, and tied to a clinical or experimental endpoint?
- How many programs are AI-originated, AI-assisted, partnered, or internally owned?
- What has advanced beyond target identification and preclinical reporting?
Regulatory and workflow questions
- Which entity owns development, validation, and regulatory responsibility for each program?
- How are model-generated hypotheses reviewed before experimental or clinical use?
- What claims are about research productivity versus a regulated product?
Data and contract questions
- Who owns generated molecules, targets, models, and derived data?
- Which proprietary datasets create defensibility and which are licensed?
- Can a partner reproduce outputs and export project data after the collaboration?
Evidence and Regulation
FDA Clearances on Record
No clearance is linked in this directory. That is not automatically a mark against the company. Some products support the people doing the work instead of reading a patient image or signal themselves.